208 related articles for article (PubMed ID: 22122223)
1. Intensifying treatment of type 2 diabetes mellitus: adding insulin.
Peters KR
Pharmacotherapy; 2011 Dec; 31(12 Suppl):54S-64S. PubMed ID: 22122223
[TBL] [Abstract][Full Text] [Related]
2. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
Lavernia F
Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
[TBL] [Abstract][Full Text] [Related]
3. Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus.
Liday C
Pharmacotherapy; 2011 Dec; 31(12 Suppl):37S-43S. PubMed ID: 22122221
[TBL] [Abstract][Full Text] [Related]
4. Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.
Cobble ME
Am J Ther; 2009; 16(1):56-64. PubMed ID: 19142156
[TBL] [Abstract][Full Text] [Related]
5. When oral agents fail: optimizing insulin therapy in the older adult.
Meece J
Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
[TBL] [Abstract][Full Text] [Related]
6. Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.
Goldman-Levine JD
Pharmacotherapy; 2011 Dec; 31(12 Suppl):44S-53S. PubMed ID: 22122222
[TBL] [Abstract][Full Text] [Related]
7. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
Tibaldi J; Rakel RE
Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
[TBL] [Abstract][Full Text] [Related]
8. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
Rakel RE
Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
10. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
11. Refining basal insulin therapy: what have we learned in the age of analogues?
Devries JH; Nattrass M; Pieber TR
Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
[TBL] [Abstract][Full Text] [Related]
12. Basal plus basal-bolus approach in type 2 diabetes.
Ampudia-Blasco FJ; Rossetti P; Ascaso JF
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S75-83. PubMed ID: 21668340
[TBL] [Abstract][Full Text] [Related]
13. Perspectives in type 2 diabetes: incorporating the latest insulin analogue strategies to achieve treatment success.
Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():iii-iv. PubMed ID: 19817775
[TBL] [Abstract][Full Text] [Related]
14. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
15. Managing special populations among patients with type 2 diabetes mellitus.
Marquess JG
Pharmacotherapy; 2011 Dec; 31(12 Suppl):65S-72S. PubMed ID: 22122224
[TBL] [Abstract][Full Text] [Related]
16. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
Dailey G
Curr Med Res Opin; 2004 Dec; 20(12):2007-14. PubMed ID: 15701217
[TBL] [Abstract][Full Text] [Related]
17. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
Yeap BB
Aust Fam Physician; 2007 Jul; 36(7):549-53. PubMed ID: 17619673
[TBL] [Abstract][Full Text] [Related]
19. [Step-wise drug therapy in type 2 diabetes mellitus].
König K; Schatz H
Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):467-73. PubMed ID: 9842691
[TBL] [Abstract][Full Text] [Related]
20. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
Tanenberg RJ
Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
